中国社区医师Issue(17)：76-76,78,2.DOI:10.3969/j.issn.1007-614x.2014.17.46
回生口服液联合肝动脉化疗栓塞术治疗原发性肝癌56例临床分析
Clinical analysis of 56 cases with primary carcinoma of the liver treated by huisheng oral liquid combined with hepatic arterial chemoembolization
梁芳 1张丽娟 1张青松 1李景梅 1邢国臣1
作者信息
- 1. 450000郑州大学附属郑州市中心医院肿瘤科
- 折叠
摘要
Abstract
Objective:To evaluate the effect of huisheng oral liquid combined with hepatic arterial chemoembolization treated on primary carcinoma of the liver.Methods:56 cases with primary carcinoma of the liver were randomly divided into the treatment group with 30 cases and the control group with 26 cases.Two groups were treated with hepatic arterial chemoembolization,and the treatment group also were given huisheng oral liquid.Results:The efficiency in the treatment group and the control group were 63.3% and 46.15% respectively,and the quality of life in two groups were 53% and 46% respectively.Conclusion:The treatment of huisheng oral liquid combined with hepatic arterial chemoembolization on advanced primary hepatocellular carcinoma can control tumor disease of patients,and improve their quality of life.关键词
回生口服液/肝动脉化疗栓塞术/原发性肝癌Key words
Huisheng oral liquid/Hepatic arterial chemoembolization/Primary carcinoma of the liver引用本文复制引用
梁芳,张丽娟,张青松,李景梅,邢国臣..回生口服液联合肝动脉化疗栓塞术治疗原发性肝癌56例临床分析[J].中国社区医师,2014,(17):76-76,78,2.
